Author | Anita T. Shaffer


Targeted Agents Boost Hormonal Therapies In Breast Cancer

November 28, 2012


Although hormonal therapy has been long established in the treatment of breast cancer, novel combinations with targeted agents show promise for improved outcomes and are likely to become part of a new paradigm for managing patients.

Study Presented at ASCO 2012 Finds Duloxetine Reduces Peripheral Neuropathy Pain

August 13, 2012


Research showing that duloxetine relieves pain associated with chemotherapy-induced peripheral neuropathy is first study to demonstrate effective pharmacotherapy for this condition.

Revised View Enhances Provenge OS Data

April 20, 2012


A further analysis of clinical trial data for sipuleucel-T (Provenge) suggests that it may have delivered a greater overall survival benefit than previously described.

Investors Eye ASCO Abstracts for Potential Winners

May 19, 2011


While oncology specialists await the latest research news from the upcoming ASCO annual meeting next month, so do legions of biopharma investors. Here's a look at companies presenting pivotol trial data at this year's conference.